Every 10-Q that Nukkleus Inc. Warrants (NUKKW) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow NUKKW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NUKKW filings page.
T3 Defense Inc. reported first‑quarter 2026 revenue of $3.7 million, reflecting new defense operations at Rimon, ITS and Tiltan. Despite this, the company posted a net loss attributable to stockholders of $27.1 million, driven largely by a $26.6 million loss from the change in fair value of stock purchase warrant liabilities.
Total assets rose to $315.5 million, including $100.2 million of goodwill from recent acquisitions such as Star 26, Nimbus and ITS, while stockholders’ equity improved to $42.5 million from a deficit a year earlier. Operating loss was $3.8 million, and cash used in operating activities was $4.9 million, partly offset by $12.5 million of financing inflows from a private placement, loans and ELOC share sales.
Management acknowledges negative working capital of about $69 million but concludes that existing cash, an equity line of credit and cash‑positive subsidiaries alleviate substantial doubt about continuing as a going concern. Subsequent events include a Nasdaq minimum bid‑price deficiency notice, a sale of Zorronet for BiomX stock and a note, debt‑for‑equity exchanges, and a share swap with VisionWave.
Nukkleus Inc. reports mixed interim results and significant financing and transaction activity. The company disclosed indicators of substantial doubt about its ability to continue as a going concern, citing a working capital deficit of approximately $53,464,000 and cash used in operating activities from continuing operations of about $2,981,000 for the six months ended June 30, 2025. The company advanced an aggregate of $2,500,000 to Star and entered an agreement to acquire a 51% interest in Star, shifting its business focus toward the defense sector. Cash at period end was $2,873,593. Common shares outstanding were 5,370,939 at June 30, 2025. The filing discloses convertible notes, multiple warrants and financing arrangements that involve discounts, potential dilution and contingent settlement features. The company recorded comprehensive income/(loss) amounts shown in the statements, and noted payments of $800,000 related to penalties tied to a private placement registration requirement.